Palvella Therapeutics

IPO

Homepage

Public · Wayne, United States · Founded 2015 · $109.7M raised

Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$109.7M
Last Round
$45.0M Series DJan 2023
Rounds
4
Type
Public

About

Palvella Therapeutics is a clinical-stage biopharmaceutical company specializing in developing medicines for patients with rare dermatological diseases with no approved therapies. Its QTORIN platform delivers topical rapamycin-based treatments, with its lead candidate in Phase 3 trials for microcystic lymphatic malformations and Phase 2 for cutaneous venous malformations.

Summary

Palvella Therapeutics is a Biotech company based in Wayne, United States, founded in 2015. It has raised $109.7M in total across 4 rounds, most recently a $45.0M Series D round in Jan 2023.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMar 2026
$230.0M

Sign up to see all 6 rounds

Corporate Round through IPO — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Palvella Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/palvella-therapeutics"><img src="https://indexed.vc/api/badge/company/palvella-therapeutics" alt="Palvella Therapeutics on Indexed.vc" width="260" height="76" /></a>